{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&humanIndexable=true&max-date=2018-11-05&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&humanIndexable=true&max-date=2018-11-05&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&humanIndexable=true&max-date=2018-11-05&_metadata=all&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&_page=0&humanIndexable=true&max-date=2018-11-05&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&humanIndexable=true&max-date=2018-11-05&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Exiting+the+European+Union+&humanIndexable=true&max-date=2018-11-05&answer.answeringMember.label=Biography+information+for+Sir+David+Davis", "items" : [{"_about" : "http://data.parliament.uk/resources/540147", "AnsweringBody" : [{"_value" : "Department for Exiting the European Union "}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/540147/answer", "answerText" : {"_value" : "<p>The Innovative Medicines Initiative is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA to boost biomedical innovation. The UK remains a member of the EU until our withdrawal is completed. UK researchers can still apply for Horizon 2020 projects. Future involvement will need to be agreed in forthcoming negotiations.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/373", "label" : {"_value" : "Biography information for Sir David Davis"}
        }
        , "answeringMemberConstituency" : {"_value" : "Haltemprice and Howden"}
        , "answeringMemberPrinted" : {"_value" : "Mr David Davis"}
        , "dateOfAnswer" : {"_value" : "2016-07-28", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2016-07-28T12:25:09.187Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "203"}
      , "answeringDeptShortName" : {"_value" : "Exiting the European Union "}
      , "answeringDeptSortName" : {"_value" : "Exiting the European Union "}
      , "date" : {"_value" : "2016-07-19", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "NHS: Drugs"}
      , "houseId" : {"_value" : "1"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
      }
      ], "questionText" : "To ask the Secretary of State for Exiting the European Union, what his policy is on future UK involvement in the Innovative Medicines Initiative.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
      }
      , "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
      , "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
      ], "uin" : "43441"}
    ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}